Saint-Romuald, Canada

Patrick Beaulieu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Patrick Beaulieu

Introduction

Patrick Beaulieu is a notable inventor based in Saint-Romuald, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that may aid in medical treatments. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Patrick Beaulieu holds one patent titled "Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use." This patent discloses compounds and pharmaceutically acceptable salts that may be utilized in treating subjects in need. The compounds are identified as inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Additionally, the patent outlines pharmaceutical compositions containing these compounds and methods for their preparation and use.

Career Highlights

Throughout his career, Patrick has demonstrated a commitment to advancing pharmaceutical science. His innovative approach has led to the development of new therapeutic options that could potentially improve patient outcomes. He is associated with Repare Therapeutics Inc., where he continues to contribute to groundbreaking research.

Collaborations

Patrick Beaulieu has collaborated with talented individuals in his field, including Janek Szychowski and Bingcan Liu. These partnerships have fostered an environment of creativity and innovation, leading to significant advancements in their research endeavors.

Conclusion

Patrick Beaulieu's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing new treatments. His ongoing efforts continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…